May 5 (Reuters) - Cytokinetics said on Tuesday its experimental heart disease drug significantly improved symptoms of a genetic heart condition in a late-stage trial. Shares of the company were up 13.

Support the American Heart Association and join us at the Go Red for Women Luncheon on May 8.

"Regular bloodwork is important if you have a known cardiovascular problem or if you are taking cholesterol medication," ...

The racial makeup and socioeconomic status of early-stage breast cancer patients could offer clues about their risk for heart ...

You can’t predict when or how you’re going to die, but you may be able to estimate what you’re more likely to die of ...

An extra portion of veg and 11 minutes more sleep are among the simple lifestyle tweaks that could help stave off ...

New research from the UC Davis School of Medicine and collaborating institutions solves the mystery of how mutations in the ...

Research shows that combining modest lifestyle tweaks can significantly improve your overall health.

The lesser-known cholesterol particle, often written as Lp(a), is gaining increasing attention from researchers and drug ...

The heart does not experience the natural world as scenery. It experiences it as biology. This is why protecting nature and ...

Two to four cups of this tea a day could reduce your risk of heart disease by up to 15%.

Swedish registry follow-up of >5.3 million pre-pandemic and >5.5 million pandemic adults linked death of a partner, child, ...